Alloclamide (Pectex, Tuselin) is an antitussive and antihistamine drug marketed in Finland and Spain. It has never been marketed in the US.

Alloclamide
Clinical data
Trade namesPectex, Tuselin
Identifiers
  • 2-(Allyloxy)-4-chloro-N-[2-(diethylamino)ethyl]benzamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H23ClN2O2
Molar mass310.82 g·mol−1
3D model (JSmol)
  • CCN(CC)CCNC(=O)C1=C(C=C(C=C1)Cl)OCC=C
  • InChI=1S/C16H23ClN2O2/c1-4-11-21-15-12-13(17)7-8-14(15)16(20)18-9-10-19(5-2)6-3/h4,7-8,12H,1,5-6,9-11H2,2-3H3,(H,18,20)
  • Key:UHWFVIPXDFZTFA-UHFFFAOYSA-N

It is sold as an oral solution, containing 6.25 mg/mL alloclamide. The recommended dosage for adults is 25 mg three to four times daily. Adverse effects include constipation and sedation.[1]

References

edit
  1. ^ Schlesser JL (1991). Drugs Available Abroad, 1st Edition. Derwent Publications Ltd. p. 6. ISBN 0-8103-7177-4.